Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART era.

Míreanna Comhchosúla

• Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients with Advanced HIV-1 Infection in the HAART Era
  le: Mizushima, Daisuke, et al.
  Foilsithe: (2013)
• Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan
  le: Nishijima, Takeshi, et al.
  Foilsithe: (2020)
• High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era.
  le: Tetsuro Kobayashi, et al.
  Foilsithe: (2016-01-01)
• High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era
  le: Kobayashi, Tetsuro, et al.
  Foilsithe: (2016)
• Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients.
  le: Takeshi Nishijima, et al.
  Foilsithe: (2013-01-01)